Cargando…

Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients

BACKGROUND: Acute pancreatitis (AP) carries a significant morbidity and mortality worldwide. AP is a potential complication of hematopoietic stem cell transplantation (HSCT) although its incidence remains unclear. HSCT recipients are at increased risk of AP due to various factors but the effect of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhry, Hunza, Dhaliwal, Armaan, Bains, Kanwal, Sohal, Aalam, Singla, Piyush, Sharma, Raghav, Dukovic, Dino, Kohli, Isha, Gupta, Gagan, Prajapati, Devang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822663/
https://www.ncbi.nlm.nih.gov/pubmed/36660472
http://dx.doi.org/10.14740/gr1579
_version_ 1784865998416904192
author Chaudhry, Hunza
Dhaliwal, Armaan
Bains, Kanwal
Sohal, Aalam
Singla, Piyush
Sharma, Raghav
Dukovic, Dino
Kohli, Isha
Gupta, Gagan
Prajapati, Devang
author_facet Chaudhry, Hunza
Dhaliwal, Armaan
Bains, Kanwal
Sohal, Aalam
Singla, Piyush
Sharma, Raghav
Dukovic, Dino
Kohli, Isha
Gupta, Gagan
Prajapati, Devang
author_sort Chaudhry, Hunza
collection PubMed
description BACKGROUND: Acute pancreatitis (AP) carries a significant morbidity and mortality worldwide. AP is a potential complication of hematopoietic stem cell transplantation (HSCT) although its incidence remains unclear. HSCT recipients are at increased risk of AP due to various factors but the effect of AP on mortality and resource utilization in the adult population has not been studied. We investigated the impact of AP on hospitalization outcomes among patients following HSCT. METHODS: We queried the National Inpatient Sample (NIS) database using the International Classification of Diseases (ICD)-10 codes. All adult patients with a diagnosis or procedure code of HSCT were included in the study. Patients were divided into those with a diagnosis of AP and those without. Sensitivity analysis was performed for patients with a length of stay greater than 28 days. The relationship between AP and mortality, length of stay, total hospitalization cost, and charges was assessed using univariate analysis followed by multivariate analysis. RESULTS: Of the 140,130 adult patients with HSCT, 855 (0.61%) patients developed AP. There was 1.74 times higher risk of mortality in patients with AP as compared to controls (adjusted odds ratio (aOR): 1.74, P = 0.0055). There was no statistically significant difference in the length of stay, hospitalization charge, or cost before sensitivity analysis. After sensitivity analysis, 13,240 patients were included, from which 125 (0.94%) had AP. There was 3.85 times higher risk of mortality in patients who developed AP as compared to controls (aOR: 3.85, P = 0.003). There was a statistically significant increase noted in the length of stay (adj coeff: 20.3 days, P = 0.002), hospital charges (+$346,616, P = 0.017), and cost (+$121,932.4, P = 0.001) in patients with AP as compared to those who did not develop AP. CONCLUSION: Recipients of HSCT who develop AP have shown to have higher mortality on sensitivity analysis. This study highlights that AP in HSCT patients is associated with worse outcomes and higher resource utilization. Physicians should be aware of this association as the presence of pancreatitis portends a poor prognosis.
format Online
Article
Text
id pubmed-9822663
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-98226632023-01-18 Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients Chaudhry, Hunza Dhaliwal, Armaan Bains, Kanwal Sohal, Aalam Singla, Piyush Sharma, Raghav Dukovic, Dino Kohli, Isha Gupta, Gagan Prajapati, Devang Gastroenterology Res Original Article BACKGROUND: Acute pancreatitis (AP) carries a significant morbidity and mortality worldwide. AP is a potential complication of hematopoietic stem cell transplantation (HSCT) although its incidence remains unclear. HSCT recipients are at increased risk of AP due to various factors but the effect of AP on mortality and resource utilization in the adult population has not been studied. We investigated the impact of AP on hospitalization outcomes among patients following HSCT. METHODS: We queried the National Inpatient Sample (NIS) database using the International Classification of Diseases (ICD)-10 codes. All adult patients with a diagnosis or procedure code of HSCT were included in the study. Patients were divided into those with a diagnosis of AP and those without. Sensitivity analysis was performed for patients with a length of stay greater than 28 days. The relationship between AP and mortality, length of stay, total hospitalization cost, and charges was assessed using univariate analysis followed by multivariate analysis. RESULTS: Of the 140,130 adult patients with HSCT, 855 (0.61%) patients developed AP. There was 1.74 times higher risk of mortality in patients with AP as compared to controls (adjusted odds ratio (aOR): 1.74, P = 0.0055). There was no statistically significant difference in the length of stay, hospitalization charge, or cost before sensitivity analysis. After sensitivity analysis, 13,240 patients were included, from which 125 (0.94%) had AP. There was 3.85 times higher risk of mortality in patients who developed AP as compared to controls (aOR: 3.85, P = 0.003). There was a statistically significant increase noted in the length of stay (adj coeff: 20.3 days, P = 0.002), hospital charges (+$346,616, P = 0.017), and cost (+$121,932.4, P = 0.001) in patients with AP as compared to those who did not develop AP. CONCLUSION: Recipients of HSCT who develop AP have shown to have higher mortality on sensitivity analysis. This study highlights that AP in HSCT patients is associated with worse outcomes and higher resource utilization. Physicians should be aware of this association as the presence of pancreatitis portends a poor prognosis. Elmer Press 2022-12 2022-12-01 /pmc/articles/PMC9822663/ /pubmed/36660472 http://dx.doi.org/10.14740/gr1579 Text en Copyright 2022, Chaudhry et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chaudhry, Hunza
Dhaliwal, Armaan
Bains, Kanwal
Sohal, Aalam
Singla, Piyush
Sharma, Raghav
Dukovic, Dino
Kohli, Isha
Gupta, Gagan
Prajapati, Devang
Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients
title Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients
title_full Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients
title_fullStr Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients
title_full_unstemmed Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients
title_short Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients
title_sort hospitalization outcomes of acute pancreatitis in hematopoietic stem cell transplant recipients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822663/
https://www.ncbi.nlm.nih.gov/pubmed/36660472
http://dx.doi.org/10.14740/gr1579
work_keys_str_mv AT chaudhryhunza hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT dhaliwalarmaan hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT bainskanwal hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT sohalaalam hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT singlapiyush hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT sharmaraghav hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT dukovicdino hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT kohliisha hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT guptagagan hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients
AT prajapatidevang hospitalizationoutcomesofacutepancreatitisinhematopoieticstemcelltransplantrecipients